Review




Structured Review

Merck KGaA gfp-targeting control sirna
Gfp Targeting Control Sirna, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gfp-targeting+control+sirna/gfp+targeting+control+sirna/pm37171229-78-19-26
Average 90 stars, based on 1 article reviews
gfp-targeting control sirna - by Bioz Stars, 2026-10
90/100 stars

Images

Related Articles

Transfection:

Article Title: Concentration-dependent effects of leptin on osteoarthritis-associated changes in phenotype of human chondrocytes.
Article Snippet: Human chondrocytes were transfected with siRNA targeting HES1 (siHES1, catalog number EHU013081, Merck Group, St Louis, Mo, USA) or GFP-targeting control siRNA (siCntrl, catalog number EHUEGFP, Merck Group, St Louis, Mo, USA) using lipofectamine RNAimax ((ThermoScientific, Malvern, Ca, USA)) following the manufacturers guidelines.

Control:

Article Title: Concentration-dependent effects of leptin on osteoarthritis-associated changes in phenotype of human chondrocytes.
Article Snippet: Human chondrocytes were transfected with siRNA targeting HES1 (siHES1, catalog number EHU013081, Merck Group, St Louis, Mo, USA) or GFP-targeting control siRNA (siCntrl, catalog number EHUEGFP, Merck Group, St Louis, Mo, USA) using lipofectamine RNAimax ((ThermoScientific, Malvern, Ca, USA)) following the manufacturers guidelines.



Similar Products

95
Addgene inc plko 1 control shrna vector targeting gfp
Plko 1 Control Shrna Vector Targeting Gfp, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gfp-targeting+control+sirna/pLKO%2E1+GFP+shRNA+(Plasmid+%2330323)/pmc12482338__10020_2025_1353_MOESM4_ESM-35-22-34
Average 95 stars, based on 1 article reviews
plko 1 control shrna vector targeting gfp - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology control sirna targeting gfp
Control Sirna Targeting Gfp, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gfp-targeting+control+sirna/GFP+siRNA/pmc12207436__pnas%2E2425015122%2Esapp-168-6-14
Average 93 stars, based on 1 article reviews
control sirna targeting gfp - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

90
Shanghai GenePharma sirna targeting green fluorescent protein (gfp; control) and estnfr
Sirna Targeting Green Fluorescent Protein (Gfp; Control) And Estnfr, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gfp-targeting+control+sirna/sirna+targeting+egfp/pm37890735-79-11-15
Average 90 stars, based on 1 article reviews
sirna targeting green fluorescent protein (gfp; control) and estnfr - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Merck KGaA gfp-targeting control sirna
Gfp Targeting Control Sirna, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gfp-targeting+control+sirna/gfp+targeting+control+sirna/pm37171229-78-19-26
Average 90 stars, based on 1 article reviews
gfp-targeting control sirna - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Bioneer Corporation sirnas targeting gfp (control)
Sirnas Targeting Gfp (Control), supplied by Bioneer Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gfp-targeting+control+sirna/sirnas+specific+for+gfp/pm35927303-249-18-30
Average 90 stars, based on 1 article reviews
sirnas targeting gfp (control) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Qiagen gfp-targeting sirna (control)
ILK is induced during LEC differentiation and inhibition of ILK retards expression of EMT markers α-SMA and fibronectin. A : Immunoblot of lysates (20 μg/lane) from immortalized and primary mouse LEC that grew out from dissected lens capsules (0-14 days). Lane 1, rhILK (500 ng); lane 2, immortalized LEC; lane 3, primary LEC, 0 days; lane 4, primary LEC, 7 days; lane 5, primary LEC, 14 days. Lysates were probed for ILK and α-SMA as an indicator of EMT. rhILK (lane 1) was used for protein size comparison, and a probe for GAPDH was used to normalize protein loading. B : Densitometry of protein bands from the blot shown in A . Relative expression values are normalized to those of GAPDH. C : Immunoblot of lysates (2 capsules/lane) from primary mouse LEC that grew out from dissected lens capsules (0-14 days). Lane 1, primary LEC + ILK-targeting <t>siRNA,</t> 7 days; lane 2, primary LEC + ILK-targeting siRNA, 14 days; lane 3, primary LEC + <t>GFP-targeting</t> siRNA (control), 7 days; lane 4, primary LEC + GFP-targeting siRNA. Lysates were probed for ILK to verify ILK-targeting siRNA efficiency. Fibronectin and α-SMA were monitored as indicators of EMT. An additional probe for GAPDH was used to normalize protein loading. D : Densitometry of protein bands from the blot shown in C . ILK- and GFP-siRNA-treated explants show a significant difference in protein expression after 14 days of culture (the asterisk indicates a p<0.02). Relative values are normalized to that of GAPDH.
Gfp Targeting Sirna (Control), supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gfp-targeting+control+sirna/sirna+targeting+gfp++sigfp+/pmc02765468-67-9-25
Average 90 stars, based on 1 article reviews
gfp-targeting sirna (control) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

95
Addgene inc plko 1 control vector targeting gfp
ILK is induced during LEC differentiation and inhibition of ILK retards expression of EMT markers α-SMA and fibronectin. A : Immunoblot of lysates (20 μg/lane) from immortalized and primary mouse LEC that grew out from dissected lens capsules (0-14 days). Lane 1, rhILK (500 ng); lane 2, immortalized LEC; lane 3, primary LEC, 0 days; lane 4, primary LEC, 7 days; lane 5, primary LEC, 14 days. Lysates were probed for ILK and α-SMA as an indicator of EMT. rhILK (lane 1) was used for protein size comparison, and a probe for GAPDH was used to normalize protein loading. B : Densitometry of protein bands from the blot shown in A . Relative expression values are normalized to those of GAPDH. C : Immunoblot of lysates (2 capsules/lane) from primary mouse LEC that grew out from dissected lens capsules (0-14 days). Lane 1, primary LEC + ILK-targeting <t>siRNA,</t> 7 days; lane 2, primary LEC + ILK-targeting siRNA, 14 days; lane 3, primary LEC + <t>GFP-targeting</t> siRNA (control), 7 days; lane 4, primary LEC + GFP-targeting siRNA. Lysates were probed for ILK to verify ILK-targeting siRNA efficiency. Fibronectin and α-SMA were monitored as indicators of EMT. An additional probe for GAPDH was used to normalize protein loading. D : Densitometry of protein bands from the blot shown in C . ILK- and GFP-siRNA-treated explants show a significant difference in protein expression after 14 days of culture (the asterisk indicates a p<0.02). Relative values are normalized to that of GAPDH.
Plko 1 Control Vector Targeting Gfp, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gfp-targeting+control+sirna/pLKO%2E1+GFP+shRNA+(Plasmid+%2330323)/10__1158_slash_1078___0432__ccr___22___1646-71-0-8
Average 95 stars, based on 1 article reviews
plko 1 control vector targeting gfp - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

90
Shanghai GenePharma small interfering rna (sirna) against the relevant genes and targeting gfp (control)
ILK is induced during LEC differentiation and inhibition of ILK retards expression of EMT markers α-SMA and fibronectin. A : Immunoblot of lysates (20 μg/lane) from immortalized and primary mouse LEC that grew out from dissected lens capsules (0-14 days). Lane 1, rhILK (500 ng); lane 2, immortalized LEC; lane 3, primary LEC, 0 days; lane 4, primary LEC, 7 days; lane 5, primary LEC, 14 days. Lysates were probed for ILK and α-SMA as an indicator of EMT. rhILK (lane 1) was used for protein size comparison, and a probe for GAPDH was used to normalize protein loading. B : Densitometry of protein bands from the blot shown in A . Relative expression values are normalized to those of GAPDH. C : Immunoblot of lysates (2 capsules/lane) from primary mouse LEC that grew out from dissected lens capsules (0-14 days). Lane 1, primary LEC + ILK-targeting <t>siRNA,</t> 7 days; lane 2, primary LEC + ILK-targeting siRNA, 14 days; lane 3, primary LEC + <t>GFP-targeting</t> siRNA (control), 7 days; lane 4, primary LEC + GFP-targeting siRNA. Lysates were probed for ILK to verify ILK-targeting siRNA efficiency. Fibronectin and α-SMA were monitored as indicators of EMT. An additional probe for GAPDH was used to normalize protein loading. D : Densitometry of protein bands from the blot shown in C . ILK- and GFP-siRNA-treated explants show a significant difference in protein expression after 14 days of culture (the asterisk indicates a p<0.02). Relative values are normalized to that of GAPDH.
Small Interfering Rna (Sirna) Against The Relevant Genes And Targeting Gfp (Control), supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gfp-targeting+control+sirna/small+interfering+rnas++sirnas+/pm34580107-64-19-24
Average 90 stars, based on 1 article reviews
small interfering rna (sirna) against the relevant genes and targeting gfp (control) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Qiagen sirna targeted control gfp-22
ILK is induced during LEC differentiation and inhibition of ILK retards expression of EMT markers α-SMA and fibronectin. A : Immunoblot of lysates (20 μg/lane) from immortalized and primary mouse LEC that grew out from dissected lens capsules (0-14 days). Lane 1, rhILK (500 ng); lane 2, immortalized LEC; lane 3, primary LEC, 0 days; lane 4, primary LEC, 7 days; lane 5, primary LEC, 14 days. Lysates were probed for ILK and α-SMA as an indicator of EMT. rhILK (lane 1) was used for protein size comparison, and a probe for GAPDH was used to normalize protein loading. B : Densitometry of protein bands from the blot shown in A . Relative expression values are normalized to those of GAPDH. C : Immunoblot of lysates (2 capsules/lane) from primary mouse LEC that grew out from dissected lens capsules (0-14 days). Lane 1, primary LEC + ILK-targeting <t>siRNA,</t> 7 days; lane 2, primary LEC + ILK-targeting siRNA, 14 days; lane 3, primary LEC + <t>GFP-targeting</t> siRNA (control), 7 days; lane 4, primary LEC + GFP-targeting siRNA. Lysates were probed for ILK to verify ILK-targeting siRNA efficiency. Fibronectin and α-SMA were monitored as indicators of EMT. An additional probe for GAPDH was used to normalize protein loading. D : Densitometry of protein bands from the blot shown in C . ILK- and GFP-siRNA-treated explants show a significant difference in protein expression after 14 days of culture (the asterisk indicates a p<0.02). Relative values are normalized to that of GAPDH.
Sirna Targeted Control Gfp 22, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gfp-targeting+control+sirna/gfp+22+sirna/pmc08160356-201-7-12
Average 90 stars, based on 1 article reviews
sirna targeted control gfp-22 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

95
Addgene inc gfp targeting control shrna plasmid
Fig. 3 FTH1 as a microtubule-stabilizing factor controlled by iron and isocitrate. a Levels of major microtubule-associated proteins (MAPs) in erythroid cells cultured from human CD34+ progenitors, from proteomic data of Gautier18. Graph: mean protein copy number per cell for five most abundant MAPs at indicated stages of differentiation. Red: Stathmin 1 (STMN1); green: ferritin heavy chain (FTH1); blue: microtubule-associated protein RP/EB family member 1 (MAPRE1); grey: microtubule-associated protein RP/EB family member 2 (MAPRE2); black: regulator of microtubule dynamics protein 1 (RMDN1); purple: microtubule-associated protein 4 (MAP4). Stages: progenitor 1 (Prog1), progenitor 2 (Prog2), proerythroblast (ProE), basophilic erythroblast 1 (Baso1), basophilic erythroblast 2 (Baso2), polychromatophilic erythroblast (Poly), and orthchromatic erythroblast (Ortho). Error bars, SEM; n = 3 biologically independent replicates for Prog1 and Prog2, and four biologically independent replicates for all other stages. b FTH1 levels by immunoblot on whole cell lysates from human CD34+ progenitors cultured 1–3 days in iron-replete (100% TSAT) or deficient (10% TSAT) erythroid medium ± isocitrate (IC). Red arrow: lysosomal proteolytic fragment. Graph: mean normalized FTH1 signal (day 2), relative to value with 100% TSAT. Error bars, SEM; n = 3 independent experiments; ***, ****P = 0.0008, 0.0003, one-way ANOVA with Tukey post hoc. c FTH1 levels by immunoblot on human CD34+ progenitors cultured 1–3 days in iron-replete or deficient erythroid medium ± protease inhibitor (5 µM CA074-me). Red arrow: proteolytic fragment. Graph: mean normalized FTH1 signal (day 2), relative to value with 100% TSAT. Error bars, SEM; n = 3 independent experiments; *, **, ***P = 0.028, 0.013, 0.0006, one-way ANOVA with Tukey post hoc. d FTH1 knockdown with lentiviral <t>shRNA.</t> Immunoblot of transduced human CD34+ progenitors cultured 3 days in iron-replete erythroid medium. e Microtubule alterations demonstrated by immunofluorescence on cells as in d. Red: β-tubulin; blue: DAPI. Graphs: microtubule (MT) density, reflected as averaged microtubule signal per cell in arbitrary units. Numbers indicate mean ± SEM; n = 4 independent experiments for assessment of FTH1#1 and three independent experiments for assessment of FTH1#2; *, ***P = 0.029, 0.0014, unpaired two-sided Student’s t test. Note: most experiments separately assessed FTH1#1 and FTH1#2. See also Supplementary Figs. 5–7 and Supplementary Data Table 1. Source data are provided as a Source data file.
Gfp Targeting Control Shrna Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gfp-targeting+control+sirna/pLKO%2E1+GFP+shRNA+(Plasmid+%2330323)/pm33712594-287-0-10
Average 95 stars, based on 1 article reviews
gfp targeting control shrna plasmid - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

Image Search Results


ILK is induced during LEC differentiation and inhibition of ILK retards expression of EMT markers α-SMA and fibronectin. A : Immunoblot of lysates (20 μg/lane) from immortalized and primary mouse LEC that grew out from dissected lens capsules (0-14 days). Lane 1, rhILK (500 ng); lane 2, immortalized LEC; lane 3, primary LEC, 0 days; lane 4, primary LEC, 7 days; lane 5, primary LEC, 14 days. Lysates were probed for ILK and α-SMA as an indicator of EMT. rhILK (lane 1) was used for protein size comparison, and a probe for GAPDH was used to normalize protein loading. B : Densitometry of protein bands from the blot shown in A . Relative expression values are normalized to those of GAPDH. C : Immunoblot of lysates (2 capsules/lane) from primary mouse LEC that grew out from dissected lens capsules (0-14 days). Lane 1, primary LEC + ILK-targeting siRNA, 7 days; lane 2, primary LEC + ILK-targeting siRNA, 14 days; lane 3, primary LEC + GFP-targeting siRNA (control), 7 days; lane 4, primary LEC + GFP-targeting siRNA. Lysates were probed for ILK to verify ILK-targeting siRNA efficiency. Fibronectin and α-SMA were monitored as indicators of EMT. An additional probe for GAPDH was used to normalize protein loading. D : Densitometry of protein bands from the blot shown in C . ILK- and GFP-siRNA-treated explants show a significant difference in protein expression after 14 days of culture (the asterisk indicates a p<0.02). Relative values are normalized to that of GAPDH.

Journal: Molecular Vision

Article Title: Expression of integrin-linked kinase in the murine lens is consistent with its role in epithelial-mesenchymal transition of lens epithelial cells in vitro

doi:

Figure Lengend Snippet: ILK is induced during LEC differentiation and inhibition of ILK retards expression of EMT markers α-SMA and fibronectin. A : Immunoblot of lysates (20 μg/lane) from immortalized and primary mouse LEC that grew out from dissected lens capsules (0-14 days). Lane 1, rhILK (500 ng); lane 2, immortalized LEC; lane 3, primary LEC, 0 days; lane 4, primary LEC, 7 days; lane 5, primary LEC, 14 days. Lysates were probed for ILK and α-SMA as an indicator of EMT. rhILK (lane 1) was used for protein size comparison, and a probe for GAPDH was used to normalize protein loading. B : Densitometry of protein bands from the blot shown in A . Relative expression values are normalized to those of GAPDH. C : Immunoblot of lysates (2 capsules/lane) from primary mouse LEC that grew out from dissected lens capsules (0-14 days). Lane 1, primary LEC + ILK-targeting siRNA, 7 days; lane 2, primary LEC + ILK-targeting siRNA, 14 days; lane 3, primary LEC + GFP-targeting siRNA (control), 7 days; lane 4, primary LEC + GFP-targeting siRNA. Lysates were probed for ILK to verify ILK-targeting siRNA efficiency. Fibronectin and α-SMA were monitored as indicators of EMT. An additional probe for GAPDH was used to normalize protein loading. D : Densitometry of protein bands from the blot shown in C . ILK- and GFP-siRNA-treated explants show a significant difference in protein expression after 14 days of culture (the asterisk indicates a p<0.02). Relative values are normalized to that of GAPDH.

Article Snippet: Six μl of HiPerFect (Qiagen) was incubated with either GFP-targeting siRNA (control) or an equimolar mixture of 3 ILK-targeting siRNA constructs (#SI01076047, #SI01076054, and #SI01076061; Qiagen) in serum-free DMEM, according to the manufacturer's protocol.

Techniques: Inhibition, Expressing, Western Blot

Fig. 3 FTH1 as a microtubule-stabilizing factor controlled by iron and isocitrate. a Levels of major microtubule-associated proteins (MAPs) in erythroid cells cultured from human CD34+ progenitors, from proteomic data of Gautier18. Graph: mean protein copy number per cell for five most abundant MAPs at indicated stages of differentiation. Red: Stathmin 1 (STMN1); green: ferritin heavy chain (FTH1); blue: microtubule-associated protein RP/EB family member 1 (MAPRE1); grey: microtubule-associated protein RP/EB family member 2 (MAPRE2); black: regulator of microtubule dynamics protein 1 (RMDN1); purple: microtubule-associated protein 4 (MAP4). Stages: progenitor 1 (Prog1), progenitor 2 (Prog2), proerythroblast (ProE), basophilic erythroblast 1 (Baso1), basophilic erythroblast 2 (Baso2), polychromatophilic erythroblast (Poly), and orthchromatic erythroblast (Ortho). Error bars, SEM; n = 3 biologically independent replicates for Prog1 and Prog2, and four biologically independent replicates for all other stages. b FTH1 levels by immunoblot on whole cell lysates from human CD34+ progenitors cultured 1–3 days in iron-replete (100% TSAT) or deficient (10% TSAT) erythroid medium ± isocitrate (IC). Red arrow: lysosomal proteolytic fragment. Graph: mean normalized FTH1 signal (day 2), relative to value with 100% TSAT. Error bars, SEM; n = 3 independent experiments; ***, ****P = 0.0008, 0.0003, one-way ANOVA with Tukey post hoc. c FTH1 levels by immunoblot on human CD34+ progenitors cultured 1–3 days in iron-replete or deficient erythroid medium ± protease inhibitor (5 µM CA074-me). Red arrow: proteolytic fragment. Graph: mean normalized FTH1 signal (day 2), relative to value with 100% TSAT. Error bars, SEM; n = 3 independent experiments; *, **, ***P = 0.028, 0.013, 0.0006, one-way ANOVA with Tukey post hoc. d FTH1 knockdown with lentiviral shRNA. Immunoblot of transduced human CD34+ progenitors cultured 3 days in iron-replete erythroid medium. e Microtubule alterations demonstrated by immunofluorescence on cells as in d. Red: β-tubulin; blue: DAPI. Graphs: microtubule (MT) density, reflected as averaged microtubule signal per cell in arbitrary units. Numbers indicate mean ± SEM; n = 4 independent experiments for assessment of FTH1#1 and three independent experiments for assessment of FTH1#2; *, ***P = 0.029, 0.0014, unpaired two-sided Student’s t test. Note: most experiments separately assessed FTH1#1 and FTH1#2. See also Supplementary Figs. 5–7 and Supplementary Data Table 1. Source data are provided as a Source data file.

Journal: Nature communications

Article Title: Iron control of erythroid microtubule cytoskeleton as a potential target in treatment of iron-restricted anemia.

doi: 10.1038/s41467-021-21938-2

Figure Lengend Snippet: Fig. 3 FTH1 as a microtubule-stabilizing factor controlled by iron and isocitrate. a Levels of major microtubule-associated proteins (MAPs) in erythroid cells cultured from human CD34+ progenitors, from proteomic data of Gautier18. Graph: mean protein copy number per cell for five most abundant MAPs at indicated stages of differentiation. Red: Stathmin 1 (STMN1); green: ferritin heavy chain (FTH1); blue: microtubule-associated protein RP/EB family member 1 (MAPRE1); grey: microtubule-associated protein RP/EB family member 2 (MAPRE2); black: regulator of microtubule dynamics protein 1 (RMDN1); purple: microtubule-associated protein 4 (MAP4). Stages: progenitor 1 (Prog1), progenitor 2 (Prog2), proerythroblast (ProE), basophilic erythroblast 1 (Baso1), basophilic erythroblast 2 (Baso2), polychromatophilic erythroblast (Poly), and orthchromatic erythroblast (Ortho). Error bars, SEM; n = 3 biologically independent replicates for Prog1 and Prog2, and four biologically independent replicates for all other stages. b FTH1 levels by immunoblot on whole cell lysates from human CD34+ progenitors cultured 1–3 days in iron-replete (100% TSAT) or deficient (10% TSAT) erythroid medium ± isocitrate (IC). Red arrow: lysosomal proteolytic fragment. Graph: mean normalized FTH1 signal (day 2), relative to value with 100% TSAT. Error bars, SEM; n = 3 independent experiments; ***, ****P = 0.0008, 0.0003, one-way ANOVA with Tukey post hoc. c FTH1 levels by immunoblot on human CD34+ progenitors cultured 1–3 days in iron-replete or deficient erythroid medium ± protease inhibitor (5 µM CA074-me). Red arrow: proteolytic fragment. Graph: mean normalized FTH1 signal (day 2), relative to value with 100% TSAT. Error bars, SEM; n = 3 independent experiments; *, **, ***P = 0.028, 0.013, 0.0006, one-way ANOVA with Tukey post hoc. d FTH1 knockdown with lentiviral shRNA. Immunoblot of transduced human CD34+ progenitors cultured 3 days in iron-replete erythroid medium. e Microtubule alterations demonstrated by immunofluorescence on cells as in d. Red: β-tubulin; blue: DAPI. Graphs: microtubule (MT) density, reflected as averaged microtubule signal per cell in arbitrary units. Numbers indicate mean ± SEM; n = 4 independent experiments for assessment of FTH1#1 and three independent experiments for assessment of FTH1#2; *, ***P = 0.029, 0.0014, unpaired two-sided Student’s t test. Note: most experiments separately assessed FTH1#1 and FTH1#2. See also Supplementary Figs. 5–7 and Supplementary Data Table 1. Source data are provided as a Source data file.

Article Snippet: GFP-targeting control shRNA plasmid, pLKO.1 GFP shRNA, was purchased from Addgene (#30323).

Techniques: Cell Culture, Western Blot, Protease Inhibitor, Knockdown, shRNA

Fig. 4 Implication of FTH1 in the erythroid iron restriction response. a, b Influence of FTH1 levels on viability and proliferation. Graphs: mean % viable cells and fold increases in cell number for human CD34+ progenitors transduced with lentiviral shRNA vectors targeting either green fluorescent protein (GFP) or ferritin heavy chain (FTH1), and cultured 4 days in iron-replete erythroid medium. Error bars, SEM; n = 3 biologically independent experiments; *, **P = 0.011, 0.009, one-way ANOVA with Tukey post hoc. NS not significant. GPA glycophorin A. c Influence of FTH1 levels on erythroid differentiation as determined by flow cytometry on cells treated as in a. d Mean fold change in GPA+ cells associated with lentiviral transductions and 4 days culture in iron- replete erythroid medium. Error bars, SEM; n = 3 independent experiments; *, **P = 0.019, 0.013, unpaired two-sided Student’s t test. Note: most experiments separately assessed FTH1#1 and FTH1#2. e Distinct consequences of ferritin enforcement in iron-replete versus iron-restricted progenitors. Flow cytometry analysis of CD34+ progenitors transduced with lentiviral (LV) expression vectors for ferritin heavy (FTH1) and light (FTL) chains followed by 4 days culture in iron-replete (100% TSAT) or deficient (10% TSAT) erythroid medium. f Mean fold change in GPA+ cells associated with ferritin enforcement in cells cultured as in e. Error bars, SEM; n = 3 independent experiments; *P = 0.02, unpaired two-sided Student’s t test. g Ferritin levels in cells transduced and cultured as in e and f, as assessed by immunoblot. LV-OE lentiviral overexpression; Vec vector. Representative results from three independent experiments. See also Supplementary Fig. 8. Source data are provided as a Source data file.

Journal: Nature communications

Article Title: Iron control of erythroid microtubule cytoskeleton as a potential target in treatment of iron-restricted anemia.

doi: 10.1038/s41467-021-21938-2

Figure Lengend Snippet: Fig. 4 Implication of FTH1 in the erythroid iron restriction response. a, b Influence of FTH1 levels on viability and proliferation. Graphs: mean % viable cells and fold increases in cell number for human CD34+ progenitors transduced with lentiviral shRNA vectors targeting either green fluorescent protein (GFP) or ferritin heavy chain (FTH1), and cultured 4 days in iron-replete erythroid medium. Error bars, SEM; n = 3 biologically independent experiments; *, **P = 0.011, 0.009, one-way ANOVA with Tukey post hoc. NS not significant. GPA glycophorin A. c Influence of FTH1 levels on erythroid differentiation as determined by flow cytometry on cells treated as in a. d Mean fold change in GPA+ cells associated with lentiviral transductions and 4 days culture in iron- replete erythroid medium. Error bars, SEM; n = 3 independent experiments; *, **P = 0.019, 0.013, unpaired two-sided Student’s t test. Note: most experiments separately assessed FTH1#1 and FTH1#2. e Distinct consequences of ferritin enforcement in iron-replete versus iron-restricted progenitors. Flow cytometry analysis of CD34+ progenitors transduced with lentiviral (LV) expression vectors for ferritin heavy (FTH1) and light (FTL) chains followed by 4 days culture in iron-replete (100% TSAT) or deficient (10% TSAT) erythroid medium. f Mean fold change in GPA+ cells associated with ferritin enforcement in cells cultured as in e. Error bars, SEM; n = 3 independent experiments; *P = 0.02, unpaired two-sided Student’s t test. g Ferritin levels in cells transduced and cultured as in e and f, as assessed by immunoblot. LV-OE lentiviral overexpression; Vec vector. Representative results from three independent experiments. See also Supplementary Fig. 8. Source data are provided as a Source data file.

Article Snippet: GFP-targeting control shRNA plasmid, pLKO.1 GFP shRNA, was purchased from Addgene (#30323).

Techniques: Transduction, shRNA, Cell Culture, Cytometry, Flow Cytometry, Expressing, Western Blot, Over Expression, Plasmid Preparation